Latest News and Press Releases

OSLO, NORWAY--(Marketwired - Feb 11, 2014) - Bionor Pharma ASA (OSE: BIONOR) announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135...

OSLO, NORWAY--(Marketwire - May 10, 2012) - Bionor Pharma (OSLO: BIONOR) News Summary Vaccine related immune responses found in HIV patients given Vacc-4x...

BANGKOK, THAILAND--(Marketwire - Sep 14, 2011) - Results from the furthest advanced study of a therapeutic vaccine candidate to treat people living with HIV/AIDS were announced at a news conference...

OSLO, NORWAY--(Marketwire - Aug 25, 2011) - Bionor Pharma ASA (OSLO: BIONOR) announces plans to conduct an exploratory clinical study using Bionor Pharma's therapeutic HIV-vaccine candidate,...

VIENNA, AUSTRIA--(Marketwire - July 22, 2010) -  Researchers at Oslo University Hospital and Bionor Pharma's subsidiary, Bionor Immuno AS today presented results from a recently conducted...

OSLO, NORWAY and WASHINGTON, DC--(Marketwire - May 10, 2010) - Mr. Rolf Henning Lem has been appointed new CFO of Nutri Pharma ASA (OSLO: NUT). As part of his duties as CFO, Mr. Henning will...

PARIS--(Marketwire - October 21, 2009) - EMBARGOED FOR RELEASE UNTIL 2:00pm CEST, or 8:00am USA EST -- Abstract #173886 -- An immunological analysis of a Phase II clinical trial demonstrated that the...

BETHESDA, MD and OSLO, NORWAY and PARIS--(Marketwire - October 19, 2009) - Bionor Immuno announced today at the AIDS Vaccine 2009 conference in Paris, France, that Robert Redfield, MD, Associate...

OSLO, NORWAY and BETHESDA, MD--(Marketwire - December 5, 2008) - Bionor Immuno officials today accepted the Norwegian Research Council's prestigious "Most Innovative Company of the Year" award. The...